RNU7-88P

Across TCGA pan-cancer cohorts, RNU7-88P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated RNU7-88P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU7-88P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-88P expression acts as an unfavorable survival marker.

OV, STAD, and KIRC are the cancer types where RNU7-88P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.359	0.849	<.001	144	view →
STAD	DFS	Tertile	II,III,IV	0.378	0.653	<.001	108	view →
KIRC	DFS	Tertile	III,IV	0.160	0.754	<.001	72	view →
ACC	OS	Tertile	All	0.113	0.822	<.001	63	view →
SARC	OS	Tertile	All	0.133	0.860	<.001	27	view →
TGCT	DFS	Tertile	All	0.067	0.802	.001	18	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

RNU7-88P–OV (OS)

Open the OV breakdown →